Founder Securities(601901)
Search documents
梦网科技: 方正证券承销保荐有限责任公司关于本次交易符合《关于加强证券公司在投资银行类业务中聘请第三方等廉洁从业风险防控的意见》相关规定的核查意见
Zheng Quan Zhi Xing· 2025-06-26 16:50
Group 1 - The company, DreamNet Cloud Technology Group Co., Ltd., plans to issue shares and pay cash to acquire all shares of Hangzhou Bicheng Digital Technology Co., Ltd., along with raising supporting funds for this transaction [1][2] - The independent financial advisor, Founder Securities, conducted a review and found no direct or indirect paid hiring of third-party institutions or individuals in this transaction [1][2] - The company has legally and compliantly hired necessary securities service institutions for this transaction, including Founder Securities as the independent financial advisor, Beijing Guofeng Law Firm as the legal advisor, Zhongxi CPA as the auditing firm, Shanghai Zhonghua Asset Appraisal Co., Ltd. for valuation, and Hong Kong Yu Peiheng Law Firm for special legal opinions regarding the Hong Kong subsidiary [1][2] Group 2 - The independent financial advisor confirmed that the hiring of the mentioned securities service institutions is in accordance with the regulations outlined in the CSRC's notice on strengthening risk prevention in investment banking [2]
诺安基金管理有限公司关于旗下部分基金增加 方正证券为销售机构并开通定投、转换业务及 参加基金费率优惠活动的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-06-25 23:09
Core Viewpoint - From June 26, 2025, certain funds managed by Nuon Fund Management Co., Ltd. will be available for purchase and redemption through Founder Securities Co., Ltd. as a sales institution [1][2]. Group 1: Fund Sales and Services - Investors can handle subscription, redemption, and related inquiries for the specified funds through Founder Securities starting June 26, 2025 [1]. - The company will also enable regular investment and conversion services for these funds at Founder Securities, along with participation in fee discount activities [1][2]. Group 2: Fund Investment Options - Starting June 26, 2025, investors can perform regular investment operations for the specified funds through Founder Securities, with the subscription fee rate being the same as the normal subscription fee rate [1][3]. - Fund conversion services will also be available for the specified funds and other convertible funds managed by the company, with rules and fees detailed in the latest prospectus [2][3]. Group 3: Fee Rate Discounts - Investors will enjoy subscription fee discounts for both subscription and regular investment operations through Founder Securities, subject to the institution's regulations [3]. - The specific standards for fund fees can be found in the latest prospectus and related legal documents published by the company [3]. Group 4: Minimum Investment Requirements - The minimum subscription amount for money market funds through Founder Securities is set at 0.01 yuan (including subscription fees), while for non-money market funds, it is set at 1 yuan (including subscription fees) [4]. - Different share classes of the same fund cannot be converted into each other [5].
方正证券:仍坚定看好创新药行情 重点关注三生制药(01530)等
智通财经网· 2025-06-25 01:39
Group 1 - The core viewpoint is that the innovative drug market is still optimistic, with ongoing revaluation of innovative drug assets and a focus on the second-generation IO and ASCO data releases, as well as the valuation reshaping of pharma companies [1][2] - The pharmaceutical index increased by 1.40% during the week of June 9-14, 2025, outperforming the CSI 300 index, which decreased by 0.25%, resulting in a relative outperformance of 1.66% [1] - The current PE (TTM) for the pharmaceutical and biological industry is 28.41 times, compared to 12.04 times for the CSI 300 index, indicating a valuation premium of 135.95% for the pharmaceutical sector, which remains at a historical low [1] Group 2 - The current innovative drug market reflects a recognition of the business model of innovative drugs, driven by leading companies like BeiGene, Innovent Biologics, and Hengrui Medicine, which are expected to turn profitable through business development or globalization in 2024 or Q1 2025 [2] - The collective rise of leading innovative drug stocks indicates a systematic revaluation of their long-term R&D investment value, with the overall valuation center of the innovative drug sector moving upward due to long-term expectations of industry upgrades [2] - The current innovative drug market is characterized by data asset pricing rather than business development pricing, where high-quality and globally leading R&D asset data will attract reasonable market valuations regardless of short-term fluctuations in business development [2]
方正证券:政策打破钴市场供给过剩预期 对钴金属价格预期乐观
Zhi Tong Cai Jing· 2025-06-24 01:52
Group 1 - The Democratic Republic of the Congo (DRC) is the world's leading cobalt supplier, accounting for 75.9% of global production in 2024, and its four-month export suspension will significantly alter market supply expectations, leading to a 14.5% price increase to 182,000 CNY/ton [1] - The DRC's cobalt reserves are substantial, with 600,000 tons out of a global total of 1,100,000 tons, representing 54.5%. The DRC's production is projected to be 220,000 tons in 2024, a 21.8% year-on-year increase, and it will contribute 86.5% of the global production increment [1] - The DRC government has strong intentions to stabilize cobalt prices, as evidenced by the price increase following the export ban, with prices rising from 159,000 CNY/ton to 182,000 CNY/ton [3] Group 2 - High copper prices provide the DRC government with the ability to control cobalt production, as local copper companies will continue operations even without exporting associated cobalt products, ensuring tax revenue for the government [2] - The export ban is expected to reshape the oversupply situation in the cobalt market, as the decline in cobalt prices since 2022 was driven by reduced demand from the ternary cathode materials and increased cobalt production from rising copper output [4]
方正证券:港币触及弱方保证对市场影响相对有限 本轮港股上涨行情有望延续
智通财经网· 2025-06-23 23:40
Core Viewpoint - The report from Founder Securities indicates that the recent fluctuations in the Hong Kong dollar (HKD) are primarily due to the Hong Kong Monetary Authority's (HKMA) large-scale liquidity injections rather than passive depreciation caused by a strengthening US dollar [1][2]. Currency Fluctuations - Since May, the HKD has experienced increased volatility, touching the weak side of the peg. As of June 23, the USD/HKD exchange rate was 7.85, a depreciation of 1.3% from the 7.75 high in early May [2]. - The HKMA typically maintains the USD/HKD exchange rate within the 7.75-7.85 range, intervening by injecting or absorbing liquidity as needed. The recent fluctuations were not due to a strengthening USD but rather the HKMA's proactive liquidity measures [2][3]. Market Concerns - Current market concerns include whether the HKMA will tighten liquidity again after the HKD touches the weak side of the peg, which historically has had a limited impact on the market [3]. - Another concern is whether low HIBOR rates will lead to significant capital outflows from the Hong Kong stock market. However, foreign capital has not been the main source of incremental funds for the market in recent years, and southbound capital continues to flow into Hong Kong stocks [3][4]. Market Outlook - The report suggests that the current uptrend in the Hong Kong stock market is likely to continue, driven by strong economic fundamentals and a series of favorable policies. The market's risk appetite has significantly improved [4]. - Southbound capital is increasingly flowing into core assets in the Hong Kong market, particularly in sectors like artificial intelligence and new consumption, which are aligned with emerging industry trends and have a degree of scarcity [4].
方正证券5月财政数据解读:财政支出维持力度保障经济增长
智通财经网· 2025-06-21 08:46
Summary of Key Points Core Viewpoint - The fiscal revenue and expenditure data for the first five months of the year indicate a mixed performance, with revenue slightly declining while expenditure shows growth, reflecting a stable fiscal environment despite challenges in revenue generation [1][2]. Group 1: Fiscal Revenue and Expenditure - From January to May, the national general public budget revenue reached 96,623 billion yuan, a year-on-year decrease of 0.3%, with the decline rate narrowing compared to the previous month [2][4]. - General public budget expenditure totaled 112,953 billion yuan, marking a year-on-year increase of 4.2%, although the growth rate has slightly decreased [2][4]. - In May alone, public fiscal revenue grew by 0.13% year-on-year, while public fiscal expenditure increased by 2.63%, both showing a certain degree of slowdown [4]. Group 2: Deficit and Budget Execution - The actual deficit from January to May reached 16,330 billion yuan, the highest in five years, compared to 11,447 billion yuan in the same period last year, representing a year-on-year increase of 4,883 billion yuan [5]. - The broad deficit, considering government funds, amounted to 32,972 billion yuan, up from 29,380 billion yuan last year, reflecting a year-on-year increase of 3,592 billion yuan [5]. - By the end of May, public fiscal revenue completed 43.9% of the annual budget, a 0.6 percentage point increase from last year, while public fiscal expenditure accounted for 38.0% of the budget, remaining stable compared to last year [6]. Group 3: Revenue Structure - Non-tax revenue showed a cumulative growth of 6.2%, although the growth rate has declined, while tax revenue decreased by 1.6%, with the decline rate narrowing [9]. - In May, tax revenue increased by 0.6% year-on-year, while non-tax revenue fell by 2.2% [9]. - Key tax categories showed varied trends, with corporate income tax declining by 2.5% year-on-year but at a reduced rate, while value-added tax increased by 2.4%, indicating improvement in corporate operations [9]. Group 4: Government Spending - Central government spending has shown significant growth, with May's expenditure rising by 11.04% year-on-year, outpacing local government spending growth of 10.1% [12]. - Expenditure in key areas such as science and technology grew by 20.15%, while cultural, tourism, and sports spending increased by 16.2% [12]. - Infrastructure spending in areas like energy conservation and environmental protection grew by 4.6%, although other sectors like transportation and rural affairs saw declines [12]. Group 5: Government Fund Budget - National government fund budget expenditure increased significantly, with a total of 32,125 billion yuan, reflecting a year-on-year growth of 16% [16]. - Government fund budget revenue reached 15,483 billion yuan, a year-on-year decrease of 6.9%, with local government fund income declining by 8.3% [16]. - Central government fund budget expenditure surged by 64.4%, while local government fund expenditure grew by 14.9% [16].
方正证券副总裁袁玉平离任,谁来扛起投行业务重任?
Xin Lang Zheng Quan· 2025-06-20 05:18
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 一纸没有感谢词的离职公告,结束了袁玉平在方正证券的投行掌舵生涯。 作为分管投行业务的副总裁,袁玉平的离任与方正投行面临的严峻挑战密不可分。2024年,方正证券公 司业务明显分化:财富管理业务和投资与交易业务成为主要增长引擎,2024年收入分别达56.64亿元和 24.96亿元,同比分别增加12.84%和127.88%。而投资银行业务出现亏损,营收较上年同期下滑 270.06%,成为公司主要业务板块中唯一亏损的部门。今年一季报数据同样不容乐观,投行业务手续费 净收入2484.30万元,较去年同期的3790.91万元,下降34.47%。人员流动方面,方正证券承销保荐有限 责任公司2024年底从业人员277名,2025年中报降至222名,减员比例高达19.86%。 | | | | 原定任期 | | 是否继续在上 | | 是否存在未 | | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 | 高任时间 | 到期日 | 离任原因 | 市公司及其控 | 具体职务 | 展行完毕的 ...
“收缩”阵地?接连撤销!
中国基金报· 2025-06-18 13:26
Core Viewpoint - The brokerage industry is undergoing a trend of branch office reductions, with over 20 brokerages announcing the closure of more than 50 branch offices in 2023, despite active market trading [2][4]. Group 1: Reasons for Branch Reductions - Brokerages are focusing on cost reduction and efficiency improvement, leading to a more centralized management of branch offices [2][6]. - The shift towards online wealth management services is becoming a prevailing trend, prompting brokerages to optimize their physical branch layouts [2][4]. Group 2: Specific Examples of Branch Closures - Caixin Securities announced the closure of three branch offices in Hangzhou, Shaoxing, and Jiaozhou, with clients being transferred to nearby offices [4]. - Founder Securities has also been actively reducing its branch offices, having closed a total of eight this year, including the Xiamen branch [4]. - Huayin Securities and Dongfang Securities have also made significant cuts, with the former closing three branches and the latter shutting down eight offices in various regions [4][6]. Group 3: Strategic Focus on Branch Optimization - The optimization of branch layouts is a core task for brokerages, aimed at concentrating resources in more promising areas [6]. - Many brokerages are leveraging financial technology to enhance online customer acquisition and reshape management models, which significantly replaces some functions of physical branch offices [6]. - The trend towards centralized operations allows brokerages to improve service efficiency and reduce costs by managing long-tail customers from headquarters [6].
核心抵债资产价值缩水、子公司净利下滑,方正证券回复监管年报问询
Di Yi Cai Jing· 2025-06-16 14:57
Core Viewpoint - The Shanghai Stock Exchange has raised five key questions regarding the 2024 annual report of Founder Securities, focusing on financial asset investments, pledged stock business, and impairment losses, which have drawn significant market attention [1][2]. Financial Asset Investment Losses - Founder Securities reported a significant loss in financial asset investments, with a total revenue of 7.718 billion yuan, up 8.42% year-on-year, and a net profit of 2.207 billion yuan, up 2.55% year-on-year for 2024 [2]. - The company's total assets reached 255.628 billion yuan, and net assets were 48.978 billion yuan by the end of 2024 [2]. - The book value of various financial investments was 113.664 billion yuan, a 14.54% increase year-on-year, but net investment income and fair value changes totaled only 1.349 billion yuan, a 13.91% decrease [2]. - Losses included 649 million yuan from trading financial assets and 1.475 billion yuan from derivative financial instruments [2]. Impairment of Core Collateral Assets - The value of collateral assets has significantly decreased, with investment properties valued at 1.188 billion yuan at the end of 2024, down from 1.763 billion yuan at the end of 2023, resulting in a fair value change loss of 590 million yuan [4]. - Major losses were attributed to the Zhengzhou Yuda International Trade Building and Beijing Jinqianguang Cinema, with losses of 493 million yuan and 87 million yuan, respectively [4][5]. Stock Pledge Business and Impairment Provisions - All stock pledge businesses were overdue, with a total balance of 886 million yuan for buy-back financial assets, and impairment provisions increased to 659 million yuan in 2024 [6]. - The company has ceased new stock pledge repurchase business, with existing projects being managed for risk [6]. Fund Lending and Impairment Discrepancies - By the end of 2024, the balance of funds lent was 42.021 billion yuan, a 28.14% increase year-on-year, with impairment provisions rising by 43.52% to 451 million yuan [7]. - Domestic impairment provisions increased significantly due to market volatility, while overseas provisions were high due to a single counterparty default [7]. Goodwill Impairment Provisions - The company reported goodwill of 4.523 billion yuan with provisions of 183 million yuan, primarily related to the acquisition of subsidiaries [8]. - Despite poor performance from one subsidiary, the company did not recognize additional goodwill impairment, citing non-recurring losses and stable operations from another subsidiary [8].
方正证券(601901.SH)回复上交所问询函:股票质押业务全部逾期,房产投资亏近6亿元
Xin Lang Cai Jing· 2025-06-16 04:13
Core Viewpoint - The announcement from the company highlights significant concerns regarding its financial performance, particularly in investment income and asset valuation, leading to regulatory scrutiny and potential risks in its operations [1][2][3] Financial Performance - In 2024, the company achieved operating revenue of 7.718 billion yuan, a year-on-year increase of 8.42%, and a net profit of 2.207 billion yuan, up 2.55% year-on-year [1] - The financial investment scale reached 113.664 billion yuan, a year-on-year growth of 14.54%, but net investment income and fair value changes combined were only 1.349 billion yuan, a decline of 13.91% year-on-year [1] Investment Asset Issues - The company's investment properties significantly impacted performance, with the book value dropping from 1.763 billion yuan to 1.188 billion yuan, resulting in a fair value loss of 590 million yuan [2] - Major losses were attributed to two key assets: Zhengzhou Yuda International Trade Building and Beijing Jinqianguang Cinema, with losses of 493 million yuan and 87 million yuan respectively due to adverse market conditions [2] Stock Pledge Business Risks - The stock pledge repurchase balance remained at 886 million yuan from 2022 to 2024, with all accounts overdue and impairment provisions increasing from 499 million yuan to 659 million yuan, resulting in a 74% impairment ratio [3] - Notable default projects included "Modern Avenue" and "Hainan Airport," with total financing balances of 359 million yuan and 527 million yuan respectively [3] - The company has ceased new stock pledge business and is working on clearing existing projects through judicial disposal and debt restructuring [3] Impairment and Valuation - The company reported significant impairment in its overseas lending, with a balance of 216 million yuan and an impairment of 140 million yuan, reflecting a 64.75% impairment rate due to a single counterparty default [3] - In contrast, domestic lending of 42.021 billion yuan had an impairment ratio of only 0.74%, consistent with industry levels [3] - The company did not recognize impairment on goodwill valued at 4.34 billion yuan, citing market method tests indicating recoverable amounts exceeding book values [3]